BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $587,934 (99.1% shares, 0.9% debt)

Holdings (30)

— BLUEPRINT MEDICINES CORP 14.3%

Value ($000) $84,070 Shares 2,102,280 Est. Cost $25.16 Unrealized —

— CHEMOCENTRYX INC 9.9%

Value ($000) $58,171 Shares 7,990,572 Est. Cost $8.92 Unrealized —

CYTK CYTOKINETICS INC 9.3%

Value ($000) $54,752 Shares 4,260,836 Est. Cost $7.03 Unrealized +66.3%

ANAB ANAPTYSBIO INC 8.2%

Value ($000) $48,246 Shares 1,738,600 Est. Cost $23.32 Unrealized 0.0%

— CONCERT PHARMACEUTICALS INC 6.8%

Value ($000) $39,863 Shares 2,336,609 Est. Cost $13.78 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 5.3%

Value ($000) $31,167 Shares 1,804,675 Est. Cost $13.98 Unrealized -5.9%

— FORWARD PHARMA A/S 5.1%

Value ($000) $29,908 Shares 1,387,853 Est. Cost $20.85 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 4.3%

Value ($000) $25,408 Shares 7,866,108 Est. Cost $3.51 Unrealized -30.0%

— ARRAY BIOPHARMA INC 4.2%

Value ($000) $24,702 Shares 2,763,086 Est. Cost $4.28 Unrealized —

— CTI BIOPHARMA CORP 3.2%

Value ($000) $18,815 Shares 4,479,691 Est. Cost $4.20 Unrealized —

— BIOLINERX LTD SPONSORED 2.9%

Value ($000) $16,809 Shares 17,500,000 Est. Cost $0.96 Unrealized —

— ONCOMED PHARMACEUTICALS INC 2.8%

Value ($000) $16,214 Shares 1,760,489 Est. Cost $16.92 Unrealized —

— GLYCOMIMETICS INC 2.6%

Value ($000) $15,347 Shares 2,826,282 Est. Cost $7.10 Unrealized —

— ACHILLION PHARMACEUTICALS INC COM 2.4%

Value ($000) $13,832 Shares 3,285,400 Est. Cost $4.15 Unrealized —

— LOXO ONCOLOGY INC 2.3%

Value ($000) $13,466 Shares 320,000 Est. Cost $42.08 Unrealized —

— CASCADIAN THERAPEUTICS INC 2.2%

Value ($000) $12,972 Shares 3,133,224 Est. Cost $4.31 Unrealized —

XENE XENON PHARMACEUTICALS INC 2.0%

Value ($000) $11,799 Shares 2,949,794 Est. Cost $9.33 Unrealized -15.7%

XOMA XOMA CORP DEL 1.8%

Value ($000) $10,685 Shares 1,502,800 Est. Cost $5.35 Unrealized -4.0%

FATE FATE THERAPEUTICS INC 1.5%

Value ($000) $8,851 Shares 1,945,245 Est. Cost $2.68 Unrealized +36.7%

— IMMUNE DESIGN CORP 1.4%

Value ($000) $8,391 Shares 1,233,976 Est. Cost $7.39 Unrealized —

— ARQULE INC 1.3%

Value ($000) $7,844 Shares 7,400,128 Est. Cost $1.87 Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.1%

Value ($000) $6,315 Shares 1,540,323 Est. Cost $4.02 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.9%

Value ($000) $5,475 Shares 10,000,000 Est. Cost $0.27 Unrealized —

— NIVALIS THERAPEUTICS INC 0.9%

Value ($000) $5,444 Shares 1,864,474 Est. Cost $6.12 Unrealized —

— GTX INC DEL 0.9%

Value ($000) $5,387 Shares 1,108,433 Est. Cost $5.28 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.8%

Value ($000) $4,984 Shares 1,917,033 Est. Cost $1.64 Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.6%

Value ($000) $3,426 Shares 8,052,073 Est. Cost $0.43 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.4%

Value ($000) $2,528 Shares 734,976 Est. Cost $3.32 Unrealized —

— PAIN THERAPEUTICS INC 0.3%

Value ($000) $2,035 Shares 2,278,552 Est. Cost $1.80 Unrealized —

— REGULUS THERAPEUTICS INC 0.2%

Value ($000) $1,028 Shares 623,000 Est. Cost $1.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,102,280	$84,070	14.3%	$25.16	—	COM	09627Y109
—	CHEMOCENTRYX INC	7,990,572	$58,171	9.9%	$8.92	—	COM	16383L106
CYTK	CYTOKINETICS INC	4,260,836	$54,752	9.3%	$7.03	+66.3%	COM NEW	23282W605
ANAB	ANAPTYSBIO INC	1,738,600	$48,246	8.2%	$23.32	0.0%	COM	032724106
—	CONCERT PHARMACEUTICALS INC	2,336,609	$39,863	6.8%	$13.78	—	COM	206022105
CTMX	CYTOMX THERAPEUTICS INC	1,804,675	$31,167	5.3%	$13.98	-5.9%	COM	23284F105
—	FORWARD PHARMA A/S	1,387,853	$29,908	5.1%	$20.85	—	SPONSORED ADR	34986J105
INFIQ	INFINITY PHARMACEUTICALS INC	7,866,108	$25,408	4.3%	$3.51	-30.0%	COM	45665G303
—	ARRAY BIOPHARMA INC	2,763,086	$24,702	4.2%	$4.28	—	COM	04269X105
—	CTI BIOPHARMA CORP	4,479,691	$18,815	3.2%	$4.20	—	COM NEW	12648L601
—	BIOLINERX LTD SPONSORED	17,500,000	$16,809	2.9%	$0.96	—	SPONSORED ADR	09071M106
—	ONCOMED PHARMACEUTICALS INC	1,760,489	$16,214	2.8%	$16.92	—	COM	68234X102
—	GLYCOMIMETICS INC	2,826,282	$15,347	2.6%	$7.10	—	COM	38000Q102
—	ACHILLION PHARMACEUTICALS INC COM	3,285,400	$13,832	2.4%	$4.15	—	COM	00448Q201
—	LOXO ONCOLOGY INC	320,000	$13,466	2.3%	$42.08	—	COM	548862101
—	CASCADIAN THERAPEUTICS INC	3,133,224	$12,972	2.2%	$4.31	—	COM NEW	14740B606
XENE	XENON PHARMACEUTICALS INC	2,949,794	$11,799	2.0%	$9.33	-15.7%	COM	98420N105
XOMA	XOMA CORP DEL	1,502,800	$10,685	1.8%	$5.35	-4.0%	COM NEW	98419J206
FATE	FATE THERAPEUTICS INC	1,945,245	$8,851	1.5%	$2.68	+36.7%	COM	31189P102
—	IMMUNE DESIGN CORP	1,233,976	$8,391	1.4%	$7.39	—	COM	45252L103
—	ARQULE INC	7,400,128	$7,844	1.3%	$1.87	—	COM	04269E107
—	SUNESIS PHARMACEUTICALS INC	1,540,323	$6,315	1.1%	$4.02	—	COM PAR	867328700
—	OREXIGEN THERAPEUTICS INC	10,000,000	$5,475	0.9%	$0.27	—	NOTE 2.750%	686164AB0
—	NIVALIS THERAPEUTICS INC	1,864,474	$5,444	0.9%	$6.12	—	COM	65481J109
—	GTX INC DEL	1,108,433	$5,387	0.9%	$5.28	—	COM NEW	40052B207
—	PIERIS PHARMACEUTICALS INC	1,917,033	$4,984	0.8%	$1.64	—	COM	720795103
—	ANTHERA PHARMACEUTICALS INC	8,052,073	$3,426	0.6%	$0.43	—	COM NEW	03674U201
—	OREXIGEN THERAPEUTICS INC	734,976	$2,528	0.4%	$3.32	—	COM NEW	686164302
—	PAIN THERAPEUTICS INC	2,278,552	$2,035	0.3%	$1.80	—	COM	69562K100
—	REGULUS THERAPEUTICS INC	623,000	$1,028	0.2%	$1.65	—	COM	75915K101